Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population

Schweikert, Bernd; Hünger, Matthias; Meisinger, Christa; König, Hans‐Helmut; Gapp, Oliver; Holle, Rolf

doi:10.1093/eurheartj/ehn509

Cited by 115 publications

(148 citation statements)

References 23 publications

Supporting

Mentioning

123

Contrasting

Unclassified

Order By: Relevance

“…Eğitim düzeyi arttıkça hastaların enerji, ağrı ve fiziksel rol kısıtlılıklarını olumlu yönde etkilendiği ve eğitim düzeyindeki artışın yaşam kalitesini arttırdığı diğer çalışmalarda da gösterilmiştir (15,16). Eğitim düzeyi yüksek bireylerde yaşam kalitesi puanlarındaki artış, bu bireylerin sağlığı koruma ve geliştirmeye yönelik daha fazla bilgiye sahip olması ve çaba sarf etmesi ile açıklanabilir.…”

Section: Discussionunclassified

“…Miyokart enfarktüsü sonrası hastalar anksiyete, depresyon, ağrı, rahatsızlık, yorgunluk, konsantrasyon bozukluğu ve uykusuzluk gibi yakınmalar yaşamakta ve yaşam kaliteleri belirgin olarak azalmaktadır (15,16). Miyokart enfarktüsü sonrası fiziksel, sosyal, psikolojik ve mesleki kısıtlılıklar, bireyin yaşam kalitesinin bozulmasında etkili olmaktadır.…”

Section: Introductionunclassified

“…Bu hastalarda tedavinin amacı sadece ömrü uzatmak değil, bunun yanında semptomları hafifletmek ve fonksiyonları iyileştirmektir. Hastaların bakım ve tedavisinde yalnızca fiziksel sonuçların değerlendirilmesi yeterli olmamakta, iyilik hali ve sağlıkla ilişkili yaşam kalitesinin değer-lendirilmesi de gerekmektedir (16,17).…”

Section: Introductionunclassified

“…Son yıllarda sağlıkla ilişkili yaşam kalitesi (SYK), tıbbi araştır-malarda kullanılmakta ve tıbbi tedavinin etkisinin değerlendiril-mesinde tamamlayıcı olarak kabul edilmektedir (16). Miyokart enfarktüsü ile ilgili tedaviler ve girişimler her geçen gün değiş-mekte ve gelişmekte, MI için geliştirilmiş yaşam kalitesi ölçüm araçları yetersiz kalmaktadır.…”

Section: Introductionunclassified

“…Kardiyovasküler hastalıklarda genel sağlığı ölçmek için geliştirilmiş ve yaygın olarak kullanılan jenerik ölçekler; Nothingam Sağlık Profili (NHP), Kısa Form 36 (SF-36), Dünya Sağlık Örgütü Yaşam Kalitesi Ölçeği (WHOQOL-BREF), Hastalık Etki Profili (SIC), EuroQol-5D (EQ-5D) Genel Yaşam Kalitesi Ölçeği'dir (16,19,20,22 (10,18,20,23). Türk toplumunda kardiyovasküler hastalıklar konusunda, sınırlı sayıda bu ölçekler ile yapılmış, göreceli az sayıda araştırma mevcuttur.…”

Section: Introductionunclassified

See 4 more Smart Citations

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

Yılmaz¹,

Eser²,

Seküri³

et al. 2011

Anadolu Kardiyol Derg

View full text Add to dashboard Cite

Objective: The purpose of this study was to describe the psychometric properties of the Myocardial Infarction Dimensional Assessment Scale (MIDAS). Methods: This is a methodological cultural adaptation study. The MIDAS consists of 35-items covering seven domains: physical activity, insecurity, emotional reaction, dependency, diet, concerns over medication, and side effects which are rated on a five-point Likert scale from 1: never to 5:always. The highest score of MIDAS is 100.Quality of life (QOL) decreases as the score of scale increases. Overall 185 myocardial infarction (MI) patients were enrolled in this study. Cronbach alpha was used for the reliability analysis. The criterion validity, structural validity, and sensitivity analysis approach was used for validity analysis. New York Heart Association (NYHA) and the Canadian Cardiovascular Society Functional Classifications (CCSFC) for testing the criterion validity; SF-36 for construct validity testing of the Turkish version of the MIDAS were used.

show abstract

Section: Discussionunclassified

Section: Introductionunclassified

See 3 more Smart Citations

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

Yılmaz¹,

Eser²,

Seküri³

et al. 2011

Anadolu Kardiyol Derg

View full text Add to dashboard Cite

show abstract

Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events

Sehested

Bjerre

et al. 2019

JAMA Cardiol

View full text Add to dashboard Cite

IMPORTANCEIn the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the risk of recurrent cardiovascular events in patients with previous myocardial infarction (MI) and high-sensitivity C-reactive protein (hs-CRP) levels of 2 mg/L or greater.OBJECTIVE To estimate the cost-effectiveness of adding canakinumab to standard of care for the secondary prevention of major cardiovascular events over a range of potential prices. DESIGN, SETTING, AND PARTICIPANTSA state-transition Markov model was constructed to estimate costs and outcomes over a lifetime horizon by projecting rates of recurrent MI, coronary revascularization, infection, and lung cancer with and without canakinumab treatment. We used a US health care sector perspective, and the base case used the current US market price of canakinumab of $73 000 per year. A hypothetical cohort of patients after MI aged 61 years with an hs-CRP level of 2 mg/L or greater was constructed.INTERVENTIONS Canakinumab, 150 mg, administered every 3 months plus standard of care compared with standard of care alone. MAIN OUTCOMES AND MEASURESLifetime costs and quality-adjusted life-years (QALYs), discounted at 3% annually.

show abstract

Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction

Nicolau

Brieger

Owen

et al. 2020

Clinical Cardiology

View full text Add to dashboard Cite

Background: Diabetes mellitus (DM) is associated with increased cardiovascular (CV) risk. We compared health-related quality of life (HRQoL), healthcare resource utilization (HRU), and clinical outcomes of stable post-myocardial infarction (MI) patients with and without DM. Hypothesis: In post-MI patients, DM is associated with worse HRQoL, increased HRU, and worse clinical outcomes. Methods: The prospective, observational long-term risk, clinical management, and healthcare Resource utilization of stable coronary artery disease study obtained data from 8968 patients aged ≥50 years 1 to 3 years post-MI (369 centers; 25 countries). Patients with ≥1 of the following risk factors were included: age ≥65 years, history of a second MI >1 year before enrollment, multivessel coronary artery disease, creatinine clearance ≥15 and <60 mL/min, and DM treated with medication. Self-reported

show abstract

Quality of life several years after myocardial infarction: comparing the MONICA/KORA registry to the general population

Abstract: MI is combined with significant reduction in HRQL compared with the general population. The main impairments occur in the dimension pain/discomfort, usual activities, and particularly anxiety/depression. The relative impairment decreases with higher ages.

Cited by 115 publications

References 23 publications

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

The psychometric properties of the Turkish version of Myocardial Infarction Dimensional Assessment Scale (MIDAS)

Cost-effectiveness of Canakinumab for Prevention of Recurrent Cardiovascular Events

Diabetes association with self‐reported health, resource utilization, and prognosis post‐myocardial infarction

Contact Info

Product

Resources

About